Adaptimmune Therapeutics PLC reports $1 million Q1 profit
The company generated $47.60 million in quarterly revenue
By USInMinutes
Published - May 12, 2023, 09:24 AM ET
Last Updated - Jul 18, 2023, 03:29 PM EDT
Adaptimmune Therapeutics PLC [ADAP] has reported fiscal Q1 profit of $1 million.
On a per-share basis, the X0 based company said its diluted earnings are $0.
The Biological Products, Except Diagnostic Substances firm posted revenue of $47.60 million in this period.
